Process development for vaccine candidates including sars COV 2 base award, COV can 8044363 total $31,202.00
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $31,202
Award facts
- Contract value 100% obligated
- $31,202.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Fixed Price Level of Effort
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Original award | $31,202 |
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $31,202.00 fixed-price level of effort contract is for process development of vaccine candidates, including for SARS-CoV-2. The award has an ultimate completion date of April 15, 2025. ABL has been awarded multiple indefinite delivery vehicles (IDVs) with NIAID, the National Institute of Neurological Disorders and Stroke (NINDS), and the National Cancer Institute (NCI), demonstrating its broad capabilities in biopharmaceutical research and development, particularly for infectious disease countermeasures and cancer prevention initiatives. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 8, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $31,202 on 75N93020F00001.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under 75N93018D00009, an indefinite delivery contract.
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award